Homocysteine‐lowering interventions (high dose) vs homocysteine‐lowering interventions (low dose)
Myocardial infarction · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (high dose) showed no clear difference in myocardial infarction compared with homocysteine‐lowering interventions (low dose) (moderate certainty).
1 finding from 1 review
- Homocysteine‐lowering interventions for preventing cardiovascular events 2017 · Cochrane Headline outcomes onlyRR 0.9 [0.66, 1.23]1 study · 3649 participantsModerate